Luciano Santel Buys Shares of Stevanato Group
Luciano Santel purchased 4,975 shares of Stevanato Group on June 12, 2026.
Key Points
- Luciano Santel bought 4,975 shares of Stevanato Group S.p.A. on June 12, 2026.
- Shares of NYSE:STVN traded near $18.39 on Friday with a market cap of $5.02 billion.
- TD Cowen initiated coverage with a 'buy' rating and a $25 target on June 16, 2026.
Important disclosure: Podchat is not a registered investment adviser, broker-dealer, or financial planner. This article is for informational and educational purposes only and is not a recommendation to buy, sell, or hold any security. Content may be generated by automated systems using public filings, market data, and third-party sources, and may contain errors or omissions. Investing involves risk, including possible loss of principal. Past performance, insider activity, analyst ratings, price targets, sentiment scores, and hypothetical or backtested results are not guarantees of future performance. Please do your own research and consult a qualified professional before making investment decisions.
Luciano Santel, an insider at Stevanato Group S.p.A. (NYSE:STVN), purchased 4,975 shares on June 12, 2026. This transaction did not involve a planned purchase under Rule 10b5-1. Shares of Stevanato Group traded near $18.39 on Friday.
Insider Buying and Selling at Stevanato Group S.p.A.
In addition to Luciano Santel's purchase, other insiders have been active. On June 12, 2026, Marco Dal Lago, the Chief Financial Officer, bought 2,356 shares. On June 15, 2026, several insiders, including Karen Flynn, William Federici, Madhavan Balachandran, and Donald Morel Jr, sold 1,493 shares each at an average price of $17.09.
Stevanato Group S.p.A. Stock Down 12.6%
Shares of Stevanato Group S.p.A. (NYSE:STVN) traded near $18.39 on Friday. The company has a market cap of approximately $5.02 billion and a P/E ratio of 31.71. Its stock has a 52-week range between $12.89 and $28.00, with a 50-day moving average of $17.39 and a 200-day moving average of $19.57. The company maintains a current ratio of 1.63 and a quick ratio of 1.11, with a debt-to-equity ratio of 29.43.
$STVN stock price
Daily closing prices, year to date. Not investment advice.
Analysts Set New Price Targets
On June 16, 2026, TD Cowen initiated coverage of Stevanato Group with a 'buy' rating and a price target of $25. Earlier, on June 2, 2026, Wolfe Research assumed coverage with a 'buy' rating and a $21 target. Morgan Stanley maintained its 'hold' rating with a $19 target on March 6, 2026. The consensus recommendation for the stock is a 'buy', with a mean price target of $24.45 from 10 analysts.
About Stevanato Group
Stevanato Group S.p.A. designs and produces products for the biopharma and healthcare industries. The company operates in two segments: Biopharmaceutical and Diagnostic Solutions, and Engineering. It offers drug containment solutions like pre-fillable syringes and vials, as well as drug delivery systems. Stevanato is headquartered in Piombino Dese, Italy, and employs over 6,000 people. Founded in 1949, it serves clients worldwide, providing solutions for pharmaceutical, biotechnology, diagnostics, and life sciences companies.
Bottom Line
Luciano Santel's purchase of Stevanato Group shares is a notable insider transaction, reflecting potential confidence in the company's future. Investors often track such insider activity for insights, though it's important to remember that these filings are backward-looking. With analyst coverage and recent insider activity, Stevanato Group remains a stock to watch in the healthcare sector.
Get Stevanato Group S.p.A. alerts
New 13F filings, insider trades, and analyst moves on $STVN, sent to your inbox. Free, and you can unsubscribe anytime.
This instant news alert was generated by automated narrative technology and financial data from Podchat and public regulatory filings. It is for informational purposes only and is not financial advice.